Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions
- 07 Dec 2015 New trial record